NeuroSense Therapeutics (NRSN) Q2 2024 Earnings

Jun 24Confirmed
Q2 2023
Q3 2023
Q1 2024
Q2 2024
-0.35
-0.2
-0.05
0.1

Details

Expected EPS
-0.205
Actual EPS
-0.35
Surprise EPS
-0.15
Surprise Percent
-70.73%

Description

⁨NeuroSense Therapeutics⁩ (⁦NRSN⁩) has reported earnings of ⁦-0.35⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts